Hazards from the Health Food Store—Part I
- Fri, 4/4/08 - 9:37am
- 0 Comments
- 6357 reads
Release Date: March 15, 2008
Expiration Date: March 15, 2009
TARGET AUDIENCE
Internists, family practitioners, geriatricians, cardiologists, and others who care for older patients.
MEDIUM USED & METHOD OF PARTICIPATION
Read the article, complete the evaluation and post-test, and return both to: NACCME via fax at (610) 560-0502. You will receive your certificate in 6-8 weeks. If you would like to print your certificate immediately, go to http://cme.naccme.com, register as a NACCME user and access the activity test and evaluation online.
SUCCESSFUL COMPLETION
Successful completion entails participants obtaining a score of at least 70% on the post-test. A certificate of completion will be mailed to the address listed on your post-test/evaluation form within 6-8 weeks of receipt of the documents.
ACCREDITATION
MD/DO:
1. Murer H, Lotscher M, Kaissling B, et al. Renal brush border membrane Na/Pi-cotransport: Molecular aspects in PTH-dependent and dietary regulation. Kidney Int 1996;49(6):1769-1773.
2. Olsson KS, Ritter B, Rosen U, et al. Prevalence of iron overload in central Sweden. Acta Med Scand 1983;213(2):145-150.
3. Summary of a report on assessment of the iron nutritional status of the United States population. Expert Scientific Working Group. Am J Clin Nutr 1985;42(6):1318-1330.
4. Prasad AS. Deficiency of zinc in man and its toxicity. In: Prasad AS, ed. Trace Elements in Human Health and Disease. New York: Academic Press; 1976:1-20.
5. Chandra RK. Excessive intake of zinc impairs immune responses. JAMA 1984;252(11):1443-1446.
6. Hooper PL, Visconti L, Garry PJ, Johnson GE. Zinc lowers high-density lipoprotein-cholesterol levels. JAMA 1980;244(17):1960-1961.
7. Rajpathak S, Rimm E, Morris JS, Hu F. Toenail selenium and cardiovascular disease in men with diabetes. J Am Coll Nutr 2005;24(4):250-256.
8. Mayer-Davis EJ, Costacou T, King I, et al; The Insulin Resistance and Atherosclerosis (IRAS) Study. Plasma and dietary vitamin E in relation to incidence of type 2 diabetes: The Insulin Resistance and Atherosclerosis Study (IRAS). Diabetes Care 2002;25(12):2172-2177.
9. Czernichow S, Couthouis A, Bertrais S, et al. Antioxidant supplementation does not affect fasting plasma glucose in the Supplementation with Antioxidant Vitamins and Minerals (SU.VI.MAX) study in France: Association with dietary intake and plasma concentrations. Am J Clin Nutr 2006;84(2):395-399.
10. Stranges S, Marshall JR, Natarajan R, et al. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: A randomized trial. Ann Intern Med 2007;147(4):217-223. Epub 2007 Jul 10.
11. Pennington JA, Schoen SA. Contributions of food groups to estimated intakes of nutritional elements: Results from the FDA total diet studies, 1982-1991. Int J Vitam Nutr Res 1996;66(4):342-349. [Erratum in: Int J Vitam Nutr Res 1997;67(3):207.]
12. Davis G, Mertz W. Copper. In: Mertz W, ed. Trace Elements in Human and Animal Nutrition. San Diego, CA: Academic Press; 1987:301-365.
13. Turnlund J. Copper. In: Shils M, Olson J, Shike, Ross AC, eds. Modern Nutrition in Health and Disease. Philadelphia, PA: Lippincott; 2000:241.
14. Delmez JA, Slatopolsky E. Hyperphosphatemia: Its consequences and treatment in patients with chronic renal disease. Am J Kidney Dis 1992;19(4):303-317.
15. Slatopolsky E. The interaction of parathyroid hormone and aluminum in renal osteodystrophy. Kidney Int 1987;31(3):842-854.
16. Netter P, Kessler M, Burnel D, et al. Aluminum in the joint tissues of chronic renal failure patients treated with regular hemodialysis and aluminum compounds. J Rheumatol 1984;11(1):66-70.
17. Andress DL, Kopp JB, Maloney NA, et al. Early deposition of aluminum in bone in diabetic patients on hemodialysis. N Engl J Med 1987;316(6):292-296.
18. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42(4 suppl 3):S1-S201.
19. Touam M, Martinez F, Lacour B, et al. Aluminium-induced, reversible microcytic anemia in chronic renal failure: Clinical and experimental studies. Clin Nephrol 1983;19(6):295-298.
20. Bjelakovic G, Nikolova D, Gluud LL, et al. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: Systematic review and meta-analysis. JAMA 2007;297(8):842-857.
Post new comment